Document is current
Any future updates will be listed below
-
Authors
Mahato, Biraj
Kaya, Koray Dogan
Fan, Yan
Sumien, Nathalie https://orcid.org/0000-0002-0077-9873
Shetty, Ritu A.
Zhang, Wei
Davis, Delaney
Mock, Thomas
Batabyal, Subrata
Ni, Aiguo
Mohanty, Samarendra
Han, Zongchao https://orcid.org/0000-0002-2019-395X
Farjo, Rafal
Forster, Michael J.
Swaroop, Anand
Chavala, Sai H.
- License Information
-
More Information
Article History
Received: 23 October 2018
Accepted: 10 February 2020
First Online: 15 April 2020
Competing interests
: B.M. and S.H.C. are listed as inventors on a pending patent application (PCT/US2018/037784), filed by the University of North Texas, that covers the chemical reprogramming method reported in this paper. S.H.C. owns equity in and is a founder of CIRC Therapeutics, Inc., a start-up company that plans to commercialize novel treatments for ocular disease related to this technology. All other authors declare no competing interests.
